To address this issue, a multistage drug delivery system carrying DDR1‐siRNA and chemotherapeutic agents is employed to disrupt collagen barriers by silencing DDR1 in tumor, enhancing chemotherapy drugs diffusion and facilitating immune infiltration. Here, DDR1 is linked to neoplasm.